MaxaltLYO

Medicinal product

(Invented) name

MaxaltLYO

Active substance (s)

Rizatriptanas

Strength

10 mg

Pharmaceutical form

geriamasis liofilizatas

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N02CC04, Rizatriptan

Marketing authorisation holder

UAB Actiofarma, Lietuva

Date of authorisation

2020-07-30

Date of renewal

Documents

1355-001-002_MaxaltLYO_2020-10-08.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Geriamajame liofilizate yra	1 vnt.
Rizatriptanas	10 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
104779	90880	1090880	lizdinė plokštelė	N3		Receptinis	LT/L/20/1355/001	Netiekiama	-	-	No	-	-	Download
104780	90881	1090881	lizdinė plokštelė	N6		Receptinis	LT/L/20/1355/002	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
	Išregistruotas
2020-07-30	Registruotas